Varlilumab: A Deep Dive into CDX-1127 and its Mechanism This therapeutic (formerly known as compound CDX-1127) represents a promising therapeutic approach targeting the CD27 receptor. This drug's mode of action https://www.targetmol.com/compound/varlilumab